Home › Daiichi Sankyo Enters Clot Drug Race With Edoxaban Study Success
 

Keywords :   


Daiichi Sankyo Enters Clot Drug Race With Edoxaban Study Success

2013-09-01 22:41:19| Food - Topix.net

Daiichi Sankyo Co.' s experimental blood thinner edoxaban was found to be as effective and safer than standard treatment warfarin in a study that clears the way for the Japanese company to compete with drugmakers including Pfizer Inc., Johnson & Johnson and Bristol-Myers Squibb Co.

Tags: study success drug race

Category:Food and Related Products

Latest from this category

All news
»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
More »